Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Pennsylvania for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Pennsylvania only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Pennsylvania (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Alan Listhaus (NPI 1205881992)

Field	Value
Entity Type	Individual
Organization	Alan Listhaus
Address	400 N 17th St
City	Allentown
State	PA
ZIP	18104
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 23, 2006

Payer Source	Total Paid
Medicare	$2.6M
Medicaid	$0

Key Findings

This provider’s revenue profile is effectively single‑payer: total Medicare revenue is $2.6M while there is no Medicaid billing on file (none). For analysts this means Medicare patterns drive nearly all observable volume and financial exposure, and Medicaid trends provide no insight into the practice.

Revenue is highly concentrated in a few high‑value services: the precomputed top three Medicare codes account for 80.6% of the provider’s Medicare dollars, and a single code, J0178, represents 63.0% of Medicare revenue ($1.6M). That concentration indicates most reimbursement is coming from medication/administration rather than a broad mix of smaller services.

The code mix points to a retina‑focused ophthalmology practice with an in‑office injection and imaging workflow: J0178 (aflibercept injection, 2.3K claims) and J2777 (faricimab, 9.4K claims) are the top drug codes, and 92134 (computerized retinal imaging, 3.4K claims) appears among the highest‑volume imaging codes. Combined with 67028 intravitreal injection (1.5K claims) and frequent established‑patient E&M activity, the pattern is consistent with chronic medical retina management (eg, wet AMD/DME) delivered in an ambulatory setting.

Operationally the provider bills substantial injection throughput: J0178 shows 2.3K claims at $692 avg paid/claim and J2777 shows 9.4K claims at $29 avg paid/claim, with 67028 at 1.5K claims; these claim counts and average payments indicate the practice performs frequent intravitreal procedures and relies on drug administrations for a majority of Medicare revenue. The ranks for these drug and injection codes are mostly in the mid‑range nationally (for example J0178 ranks #386 of 3204 and is described as "typical, unremarkable volume"), so the practice’s injection program is substantial but not universally exceptional compared with peers.

Several encounter and imaging codes are extreme national outliers, reflecting very high patient throughput: 92014 (established comprehensive eye exam) ranks #179 of 35415 and 92134 (retinal imaging/OCT) ranks #250 of 26868 — both labeled "extreme outlier, far above typical national volume." Likewise 99213 is a 99th‑percentile "extreme outlier" for office visit volume. These signals suggest unusually high visit and imaging volume relative to most U.S. ophthalmologists, even as drug administration ranks remain more typical.

Use of non‑aflibercept agents and unclassified biologics is limited in scale: J2778 (ranibizumab) appears with 575 claims and $104.1K revenue (46th percentile, typical) and J3590 (unclassified biologics) has 27 claims/$57.2K revenue (15th percentile, typical). This pattern suggests clinical reliance on aflibercept as the primary anti‑VEGF agent with smaller, selective use of other biologic products.

The provider has a long active tenure in the Medicare program — NPI enumerated on 2006-05-23 (~20 years ago) — indicating an established practice history that aligns with sustained high exam/imaging volumes and a mature injection service line. For network or contracting teams, that tenure plus the concentrated Medicare revenue profile signals a stable, well‑established Medicare patient base.

For payers and contractor evaluators the combination of a single‑payer footprint (Medicare $2.6M; Medicaid none), heavy concentration in J0178 (63.0% of Medicare revenue) and the extreme outlier status of exam and imaging codes suggests negotiations or utilization reviews should focus on drug administration protocols, injection scheduling, and imaging utilization patterns rather than on Medicaid rate considerations. The data indicate financial and operational leverage is centered on Medicare‑paid intravitreal drug and follow‑up visit throughput.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,330	$690	$1.6M
J2777	Injection, faricimab‑svoa, 0.1 mg	9,420	$30	$273.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,220	$80	$177.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,500	$80	$122.8K
J2778	Injection, ranibizumab, 0.1 mg	580	$180	$104.1K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,380	$30	$94.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,010	$70	$65.3K
J3590	Unclassified biologics	30	$2,120	$57.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	320	$90	$28.7K
67210	The provider destroys a lesion of the retina using a laser beam that heats up the tissue.	20	$400	$8.7K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Pennsylvania Distribution

Alan Listhaus — 3 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Pennsylvania

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	26	140	830	$690	$865.1K
J2778	46	70	1,030	$190	$417.1K
J2777	42	100	7,950	$30	$360.2K
67028	41	180	600	$90	$87.5K
J3590	7	10	40	$1,690	$78K
92014	6	1,570	130	$80	$21K
67210	18	30	30	$370	$16K
99214	3,952	23,230	100	$80	$14.5K
92235	36	70	40	$100	$10K
92134	25	1,320	60	$30	$8.4K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Alan Listhaus, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Rabady	NY	Retina Specialist (Ophthalmology) Physician	$3.8M	$1.1M
Christopher Seebruck	PA	Ophthalmology Physician	$2.9M	$442.2K
Matthew Pomykala	NY	Ophthalmology Physician	$1.7M	$1M
Brian Jewart	PA	Ophthalmology Physician	$2.2M	$266.4K
Miguel Busquets	KY	Retina Specialist (Ophthalmology) Physician	$2.4M	$54.4K
Remington Horesh	FL	Ophthalmology Physician	$2M	$11.6K
Tailun Zhao	CA	Retina Specialist (Ophthalmology) Physician	$1.8M	$139.9K
Ravi Patel	NJ	Retina Specialist (Ophthalmology) Physician	$1.7M	$84.4K
Jeffrey Bezier	PA	Ophthalmology Physician	$1.6M	$31.2K
Michael Shumski	FL	Ophthalmology Physician	$497.7K	$0

Nearby Providers

Other providers in the same ZIP code as Alan Listhaus, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
St. Luke's Hospital	PA	General Acute Care Hospital	$0	$23.4M
Loving Care Agency, Inc.	PA	Home Health Agency	$0	$21.2M
The Salvation Army	PA	Nursing Care Agency	$0	$17.9M
Maxim Healthcare Services, Inc.	PA	Home Health Agency	$0	$16M
Valley Health Partners Community Health Center	PA	Federally Qualified Health Center (FQHC)	$0	$11.9M
Pyramid Healthcare Inc.	PA	Substance Use Disorder Rehabilitation Clinic/Center	$0	$11M
Horizon House, Inc.	PA	Community/Behavioral Health Agency	$0	$8.2M
Lehigh Valley Physician Group	PA	Pediatrics Physician	$0	$7.6M
Cetronia Ambulance Corps, Inc	PA	Land Ambulance	$1.7M	$4.3M
Surgery Center Of Allentown LLC	PA	Ambulatory Surgical Clinic/Center	$2M	$0

Alan Listhaus — Billing Profile & Reimbursement Data

Sign up for Alan Listhaus — Billing Profile & Reimbursement Data policy alerts

Alan Listhaus — Billing Profile & Reimbursement Data

Sign up for Alan Listhaus — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References